Best Healthcare Companies in Princeton, United States
The 76 best Healthcare companies in Princeton, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: CitiusTech.
Ranked: Best Healthcare companies in Princeton
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CitiusTech 🦄 Provider of digital solutions and services for the healthcare and life sciences | $1.1B | 44 mo ago | 4,760 4,760 → 6,642 (+40%) | Rizwan Koita Co-Founder | HubSpot CMS HubZohoSalesforce+28 | Top 1M | — | 1 partnership · 1 award |
| 2 | Covance Lab R&D drug testing for biopharma, advancing therapeutic development | $250M | 63 mo ago | 10,718 | — | — | — | 23 patents Frozen tissue microarray platforms and moisture‑controlled sample handling for biomedical analysis | — |
| 3 | Indegene Suite solutions for payers and healthcare providers | $220M | 62 mo ago | 350 | Anand Kiran Co-Founder & EVP of Global Operations | ZohoSalesforceNode.js+27 | Top 1M | — | — |
| 4 | Bionpharma Manufacturer & supplier of prescription and OTC generic products | $37M | 126 mo ago | 38 | Venkat Krishnan President & CEO | WordPressMySQLPHP+15 | Top 50M | — | — |
| 5 | Laureate Biopharmaceutical Services Biologics CDMO, now a part of Patheon/Thermo Fisher | $20M | 185 mo ago | 106 | James Mullen CEO | — | — | — | — |
| 6 | Zennova Manufacturer of drugs | $14M | 35 mo ago | — | Dahai Guo Co-Founder & CEO | — | — | 3 patents Analyzing dissolution and solubility of poorly soluble compounds in complex media | — |
| 7 | Endovalve Limited information available | $10M | 231 mo ago | — | Tracy Warren Founder | — | — | 28 patents Implantable cardiac valve prostheses, especially mitral valve devices and placement methods | — |
| 8 | Conjupro Biotherapeutics Biopharmaceutical company offering diversified research and development solutions | $9M | 33 mo ago | 18 | Qingxi Wang CEO | — | — | — | — |
| 9 | Diligent Provider of contract based clinical trial and quality management services | $8M | 37 mo ago | 24 | — | — | — | 17 patents Data storage/search systems and tape emulation for open-system environments | — |
| 10 | Populus Health Technologies Provider of virtual care platform connecting brands and healthcare professionals 40Growth top 35%Tech top 35%Talent top 38%Funding bottom 47% All 6 signals ▾Growthtop 35% Techtop 35% Talenttop 38% Fundingbottom 47% Globalbottom 34% Marketbottom 25% Growth: Fresh capital in last 24 mo Tech: 28 technologies across 6/8 capability areas · Cloud: Amazon Web Services rank vs industry peers · Fliar Intelligence Index 40/100 | $8M | 19 mo ago | — | Satnam Gandhi Co-Founder & CTO | WordPressMySQLPHP+17 | Top 50M | — | — |
| 11 | Ricovr Diversified medical device company | $5M | 6 mo ago | 11 | Himanshu Bhatia Founder & CEO | WordPressMySQLPHP+24 | Top 50M | — | 1 launch |
| 12 | Actify Neurotherapies Chain of mental health care clinics | $5M | 79 mo ago | 6 | — | — | — | — | — |
| 13 | Ventis Medical Manufacturer of ventilators 22Talent top 28%Tech bottom 46%Funding bottom 45%Global bottom 29% All 5 signals ▾Talenttop 28% Techbottom 46% Fundingbottom 45% Globalbottom 29% Marketbottom 20% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Tech: 15 technologies across 4/8 capability areas · Cloud: Google Cloud, Google Cloud Cdn rank vs industry peers · Fliar Intelligence Index 22/100 | $4M | 21 mo ago | 7 | Glenn Laub Founder | Wix eCommerceWixSentry+12 | Top 50M | — | — |
| 14 | Abeille Pharmaceuticals Late-stage drug development company focusing on oncology and diabetes, with expertise in oral sustained… | $3M | 207 mo ago | — | Suresh Borsadia CEO & President | — | — | — | — |
| 15 | Inaedis Provider of biological drugs research and development services | $3M | 12 mo ago | — | Maksim Mezhericher Founder & CEO | — | — | — | — |
| 16 | Avicenna Therapeutics Provider of pharmaceutical products | $3M | 41 mo ago | — | Jan Scicinski Founder President and CEO | — | — | — | — |
| 17 | Longevica Provider of research, clinical studies, technology, and development of drugs | $3M | 45 mo ago | — | — | — | — | — | — |
| 18 | Origin Developer of drug delivery platform for skin and soft-tissue infections | $2M | 32 mo ago | 7 | — | — | — | 148 patents Medical nitric oxide generation and delivery devices for therapeutic and diagnostic applications | — |
| 19 | Soterius Provider of pharmacovigilance, medical affairs, and regulatory services for pharma | $2M | 75 mo ago | 38 | Suneet Walia Founder & CEO | WordPressMySQLPHP+39 | Top 5M | — | 2 job openings · 2 partnerships |
Top 12 Healthcare companies in Princeton
#1
Seed · Princeton, New Jersey · founded 2017 · 11 employees$5Mraised▾
Diversified medical device company
- Dec 2025Seed$550K
- Apr 2025Grant (prize money)$350K
- Sep 2024Grant (prize money)$295.9K
- Jul 2024Grant (prize money)$295.6K
#2
Funding Raised · Princeton, New Jersey · founded 2022$3.1Mraised▾
Provider of biological drugs research and development services
- Jun 2025Grant (prize money)$1.2M
- May 2025Grant (prize money)$1.2M
- Dec 2023Grant (prize money)$312.6K
- Sep 2023Grant (prize money)$275K
#3
Acquired · Princeton, New Jersey · founded 2005 · 4760 employees$1.1Braised▾
Provider of digital solutions and services for the healthcare and life sciences. The company offers consulting, data engineering, cloud services, and cybersecurity. It delivers platforms and products for data management, interoperability, and regulatory compliance. The company focuses on AI, analytics, and digital engineering to transform healthcare operations.
- Oct 2022PE$960M
- Mar 2014PE$111.2M
#4
Series A · Princeton, New Jersey · founded 2018$7.5Mraised▾
Provider of virtual care platform connecting brands and healthcare professionals. The platform facilitates communication between life science brands and healthcare professionals within virtual consultations. It enables targeted messaging to patients during inquiry with healthcare professionals. The platform also provides healthcare professionals access to clinical messaging within their digital workflow. It aims to expand brand reach to a condition-specific audience.
- Nov 2024Series A$5M
- Aug 2021Conventional Debt$2.5M
#5
Series B · Princeton, New Jersey · founded 2020 · 7 employees$4Mraised▾
Manufacturer of ventilators
- Sep 2024Series B$3M
- Nov 2023Series A$1M
- Jun 2021Seed—
#6
Public · Princeton, New Jersey · founded 1998 · 350 employees$220Mraised▾
Suite solutions for payers and healthcare providers. The payer solutions portfolio includes transformation, care management, member acquisition and engagement, healthcare analytics, and medicare analysis; and the ACO solutions portfolio comprises transformation services, outcomes improvement, patient engagement, and analytics. It also operates cloud-based platforms for customer engagement, member loyalty & retention, and care management.
- Apr 2021Series C$35.2M
- Feb 2021PE$200M
- Jan 2020PE$20M
- 2002PE—
#7
Acquired · Princeton, New Jersey · founded 1996 · 10718 employees$250.3Mraised▾
Lab R&D drug testing for biopharma, advancing therapeutic development. They navigate the complexities of drug development with scientific laboratory services. They offer solutions that inform every development phase and support targeted therapeutic indications, including emerging treatment modalities. Services include nonclinical development with toxicology, pharmacology, and metabolism expertise, central lab services for clinical trial data generation, and commercialization services for biomarker-driven trials and companion diagnostics. They expedite drug development and bring new therapies to patients faster through scientific and operational leadership, advanced technology, and global lab testing capacity. They provide actionable insights with quality data and expert analysis, adhering to compliance, privacy, and security standards. They support biopharmaceutical partners, investigator sites, and patients from drug discovery to clinical trial testing and diagnostic development and commercialization.
- Mar 2021Grant (prize money)$304.4K
- Nov 2013Venture Debt$250M
#8
Series B · Princeton, New Jersey · founded 2014$13.9Mraised▾
Manufacturer of drugs
- Jul 2023Series B$13.9M
- Aug 2021Series A—
#9
Series A · Princeton, New Jersey · founded 2017 · 18 employees$9.3Mraised▾
Biopharmaceutical company offering diversified research and development solutions. It provides pre-clinical research and development services, and develops medicines in oncology, central nervous system, and infectious disease areas.
- Sep 2023Series A$9.3M
#10
Series A · Princeton, New Jersey · founded 2018 · 24 employees$8.3Mraised▾
Provider of contract based clinical trial and quality management services
- May 2023Series A$8.3M
#11
Seed · Princeton, New Jersey · founded 2010 · 7 employees$1.9Mraised▾
Origin is involved in developing a drug delivery platform for skin and soft-tissue infections such as diabetic foot ulcers. They have developed a patented technology, IonoJet, which enables targeted delivery of nitric oxide (directly to treatment site), produced at the point of therapy from room air in a vehicle. Their products include IonoStim (for wound healing), Ionoderma (for onychomycosis), Ionosite (for arthritis and tendinitis), and Ionodent (for periodontitis and implantitis).
- Oct 2023Seed$51K
- Jun 2023Seed$500K
- May 2017Seed$1.3M
#12
Series A · Princeton, New Jersey · founded 2014 · 38 employees$37.2Mraised▾
Manufacturer & supplier of prescription and OTC generic products. The company develops and distributes generic pharmaceutical products and is accomplished in the areas of product development, regulatory affairs, quality management, sales and distribution, and supply chain management, enabling clients to get soft gel capsules in the US market.
- Dec 2015Series A$6.5M
- May 2015Series A$30.7M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.